Swallow Diane Ma, Counsell Carl E
Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
J R Coll Physicians Edinb. 2023 Mar;53(1):74-79. doi: 10.1177/14782715231153033. Epub 2023 Feb 2.
The effectiveness of any healthcare-related research governance system is dependent on its ability to identify, challenge and change practices that compromise its ability to deliver timely, proportionate review. We present a case study outlining our experience of obtaining research ethics committee (REC) and Public Benefit and Privacy Panel (PBPP) for Health and Social Care approval to conduct a study which aimed to collect data on diagnostic and care pathways and determine the national prevalence of two rare diseases in Scotland. We discuss the threats posed to low-risk observational epidemiological research by disproportionate governance practices and propose practical solutions. In the context of increasing investment, the ever-increasing barriers to doing high-quality, low-risk epidemiological research using patient-identifiable information is concerning. Information governance committees, guided by clinical researchers, must step up as leaders in this area, making use of flexibilities and opportunities within the law.
任何与医疗保健相关的研究治理体系的有效性取决于其识别、质疑和改变那些损害其提供及时、适度审查能力的做法的能力。我们呈现一个案例研究,概述我们在获得卫生与社会保健研究伦理委员会(REC)和公共利益与隐私小组(PBPP)批准以开展一项研究方面的经验,该研究旨在收集有关诊断和护理途径的数据,并确定苏格兰两种罕见疾病的全国患病率。我们讨论了不相称的治理做法对低风险观察性流行病学研究构成的威胁,并提出了切实可行的解决方案。在投资不断增加的背景下,利用可识别患者信息进行高质量、低风险流行病学研究的障碍日益增加,这令人担忧。由临床研究人员指导的信息治理委员会必须在这一领域发挥领导作用,利用法律赋予的灵活性和机会。